Formulation and Optimization of Transdermal Patches - Couverture souple

Rani, Mukesh ; Rohilla, Seema

9786208427764: Formulation and Optimization of Transdermal Patches

Couverture souple

ISBN 10 : 6208427762 ISBN 13 : 9786208427764

Editeur : LAP Lambert Academic Publishing, 2025

Afficher les exemplaires de cette �dition comportant l'ISBN

0 D'occasion

11 Neuf

De EUR 83,58

D�tails de l'�dition

�diteur: LAP Lambert Academic Publishing
Date d'�dition: 2025
Langue: anglais
ISBN 10: 6208427762
ISBN 13: 9786208427764
Reliure: Broch�
Nombre de pages: 188
Coordonn�es du fabricant: non disponible
Personne responsable: KreGa Onlinehandel GmbH
4950000000000
info@krega-onlinehandel.de

Birkenweg 31
Brakel
33034
Allemagne

R�sultats de recherche pour Formulation and Optimization of Transdermal Patches

Image d'archives

Formulation and Optimization of Transdermal Patches

Rani, Mukesh; Rohilla, Seema

Edit� par LAP LAMBERT Academic Publishing, 2025

ISBN 10 : 6208427762 ISBN 13 : 9786208427764

Neuf PAP

Vendeur : PBShop.store US, Wood Dale, IL, Etats-Unis

�valuation du vendeur 5 sur 5 �toiles

PAP. Etat : New. New Book. Shipped from UK. Established seller since 2000. N� de r�f. du vendeur L2-9786208427764

Contacter le vendeur

Acheter neuf

EUR 83,58

Livraison gratuite
Exp�dition nationale�: Etats-Unis

Quantit� disponible : Plus de 20 disponibles

Ajouter au panier

Image d'archives

Formulation and Optimization of Transdermal Patches

Rani, Mukesh; Rohilla, Seema

Edit� par LAP LAMBERT Academic Publishing, 2025

ISBN 10 : 6208427762 ISBN 13 : 9786208427764

Neuf PAP

Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni

�valuation du vendeur 5 sur 5 �toiles

PAP. Etat : New. New Book. Shipped from UK. Established seller since 2000. N� de r�f. du vendeur L2-9786208427764

Contacter le vendeur

Acheter neuf

EUR 81,61

Exp�dition �EUR 4,85
Exp�dition depuis Royaume-Uni vers Etats-Unis

Quantit� disponible : Plus de 20 disponibles

Ajouter au panier

Image d'archives

Formulation and Optimization of Transdermal Patches

Rani, Mukesh; Rohilla, Seema

Edit� par LAP Lambert Academic Publishing, 2025

ISBN 10 : 6208427762 ISBN 13 : 9786208427764

Neuf Couverture souple

Vendeur : California Books, Miami, FL, Etats-Unis

�valuation du vendeur 4 sur 5 �toiles

Etat : New. N� de r�f. du vendeur I-9786208427764

Contacter le vendeur

Acheter neuf

EUR 91,10

Livraison gratuite
Exp�dition nationale�: Etats-Unis

Quantit� disponible : Plus de 20 disponibles

Ajouter au panier

Image d'archives

Formulation and Optimization of Transdermal Patches

Mukesh Rani

Edit� par LAP LAMBERT Academic Publishing Aug 2025, 2025

ISBN 10 : 6208427762 ISBN 13 : 9786208427764

Neuf Taschenbuch

impression � la demande

Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne

�valuation du vendeur 5 sur 5 �toiles

Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 188 pp. Englisch. N� de r�f. du vendeur 9786208427764

Contacter le vendeur

Acheter neuf

EUR 79,90

Exp�dition �EUR 23
Exp�dition depuis Allemagne vers Etats-Unis

Quantit� disponible : 2 disponible(s)

Ajouter au panier

Image d'archives

Formulation and Optimization of Transdermal Patches (Paperback)

Mukesh Rani

Edit� par LAP Lambert Academic Publishing, 2025

ISBN 10 : 6208427762 ISBN 13 : 9786208427764

Neuf Paperback

impression � la demande

Vendeur : CitiRetail, Stevenage, Royaume-Uni

�valuation du vendeur 5 sur 5 �toiles

Paperback. Etat : new. Paperback. Lisinopril is an antihypertensive agent indicated for the prevention of hypertension, acute myocardial infarction and diabetic nephropathy. It is an angiotensin converting enzyme(ACE) inhibitor. It has a short half-life and undergoes variable first pass metabolism. It is required to be administered two or three times daily which results in poor patient compliance. In this work an attempt was made to formulate & evaluate TDDS for sustained release of lisinopril by solvent evaporation method. Low molecular weight, good permeability and shorter half-life of the drug made it a suitable candidate for the development of trans dermal patch.The main objective of formulating the transdermal system was to prolong the drug release time, reduce the frequency of administration and to improve patient compliance. The compatibility characterization was done by IR method. By using 32factorial design nine formulations were prepared using hydrophilic (HPMC) andhydrophobic (ethyl cellulose) polymers along with selected plasticizer & permeationenhancer. PVA backing membrane was used as a substrate for pouring the polymeric solution. The prepared patches were evaluated for physical appearance, thickness. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. N� de r�f. du vendeur 9786208427764

Contacter le vendeur

Acheter neuf

EUR 87,69

Exp�dition �EUR 43,15
Exp�dition depuis Royaume-Uni vers Etats-Unis

Quantit� disponible : 1 disponible(s)

Ajouter au panier

Image fournie par le vendeur

Formulation and Optimization of Transdermal Patches | A brief study

Mukesh Rani (u. a.)

Edit� par LAP LAMBERT Academic Publishing, 2025

ISBN 10 : 6208427762 ISBN 13 : 9786208427764

Neuf Taschenbuch

Vendeur : preigu, Osnabr�ck, Allemagne

�valuation du vendeur 5 sur 5 �toiles

Contacter le vendeur

Acheter neuf

EUR 67,20

Exp�dition �EUR 70
Exp�dition depuis Allemagne vers Etats-Unis

Quantit� disponible : 5 disponible(s)

Ajouter au panier

Image fournie par le vendeur

Formulation and Optimization of Transdermal Patches

Mukesh Rani

Edit� par LAP LAMBERT Academic Publishing Aug 2025, 2025

ISBN 10 : 6208427762 ISBN 13 : 9786208427764

Neuf Taschenbuch

impression � la demande

Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne

�valuation du vendeur 5 sur 5 �toiles

Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Lisinopril is an antihypertensive agent indicated for the prevention of hypertension, acute myocardial infarction and diabetic nephropathy. It is an angiotensin converting enzyme(ACE) inhibitor. It has a short half-life and undergoes variable first pass metabolism. It is required to be administered two or three times daily which results in poor patient compliance. In this work an attempt was made to formulate & evaluate TDDS for sustained release of lisinopril by solvent evaporation method. Low molecular weight, good permeability and shorter half-life of the drug made it a suitable candidate for the development of trans dermal patch.The main objective of formulating the transdermal system was to prolong the drug release time, reduce the frequency of administration and to improve patient compliance. The compatibility characterization was done by IR method. By using 32factorial design nine formulations were prepared using hydrophilic (HPMC) andhydrophobic (ethyl cellulose) polymers along with selected plasticizer & permeationenhancer. PVA backing membrane was used as a substrate for pouring the polymeric solution. The prepared patches were evaluated for physical appearance, thickness.VDM Verlag, Dudweiler Landstra�e 99, 66123 Saarbr�cken 188 pp. Englisch. N� de r�f. du vendeur 9786208427764

Contacter le vendeur

Acheter neuf

EUR 79,90

Exp�dition �EUR 60
Exp�dition depuis Allemagne vers Etats-Unis

Quantit� disponible : 1 disponible(s)

Ajouter au panier

Image fournie par le vendeur

Formulation and Optimization of Transdermal Patches : A brief study

Mukesh Rani

Edit� par LAP LAMBERT Academic Publishing, 2025

ISBN 10 : 6208427762 ISBN 13 : 9786208427764

Neuf Taschenbuch

impression � la demande

Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne

�valuation du vendeur 5 sur 5 �toiles

Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Lisinopril is an antihypertensive agent indicated for the prevention of hypertension, acute myocardial infarction and diabetic nephropathy. It is an angiotensin converting enzyme(ACE) inhibitor. It has a short half-life and undergoes variable first pass metabolism. It is required to be administered two or three times daily which results in poor patient compliance. In this work an attempt was made to formulate & evaluate TDDS for sustained release of lisinopril by solvent evaporation method. Low molecular weight, good permeability and shorter half-life of the drug made it a suitable candidate for the development of trans dermal patch.The main objective of formulating the transdermal system was to prolong the drug release time, reduce the frequency of administration and to improve patient compliance. The compatibility characterization was done by IR method. By using 32factorial design nine formulations were prepared using hydrophilic (HPMC) andhydrophobic (ethyl cellulose) polymers along with selected plasticizer & permeationenhancer. PVA backing membrane was used as a substrate for pouring the polymeric solution. The prepared patches were evaluated for physical appearance, thickness. N� de r�f. du vendeur 9786208427764

Contacter le vendeur